首页 > 最新文献

Current Opinion in Ophthalmology最新文献

英文 中文
Management of diabetic tractional retinal detachments: surgical experiences from a large tertiary academic institution. 糖尿病牵引性视网膜脱离的治疗:来自某大型高等院校的手术经验。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-14 DOI: 10.1097/ICU.0000000000001124
Albert Liao, Blake Fortes, Adrian Au, Kirk Hou

Purpose of review: Management of diabetic tractional retinal detachments (TRDs) remains technically challenging. The purpose of this review is to provide an updated overview of current surgical techniques and important considerations when treating this condition.

Recent findings: Recent advances in imaging have provided critical insights into hyaloid status and tractional forces in diabetic TRDs, greatly aiding surgical planning. Updates in vitrectomy instruments have also greatly improved anatomic success rates. However, a comprehensive preoperative evaluation and plan remains key in optimizing visual outcomes for this difficult condition.

Summary: The surgical management of diabetic TRDs requires several key elements for successful outcomes. Timely intervention and presurgical planning are crucial, particularly in rapidly progressing cases. The use of advanced imaging and instruments enhances visualization and precision during surgery. Finally, a collaborative multispecialty approach with clear communication with patients about their prognosis is fundamental to effective care. These strategies collectively improve patient outcomes and promote visual recovery in those affected by diabetic TRDs.

综述的目的:糖尿病牵引性视网膜脱离(TRDs)的治疗在技术上仍然具有挑战性。本综述的目的是提供当前手术技术的最新概述和治疗这种疾病时的重要注意事项。最近的发现:最近的影像学进展为糖尿病trd的透明体状态和牵引力提供了重要的见解,极大地帮助了手术计划。玻璃体切割仪器的更新也大大提高了解剖成功率。然而,全面的术前评估和计划仍然是优化视力结果的关键。总结:糖尿病trd的手术治疗需要几个关键因素才能获得成功的结果。及时干预和术前计划是至关重要的,特别是在进展迅速的病例中。在手术过程中,先进的成像和仪器的使用提高了可视化和精确性。最后,与患者就其预后进行明确沟通的多专业合作方法是有效护理的基础。这些策略共同改善了患者的预后,促进了糖尿病trd患者的视力恢复。
{"title":"Management of diabetic tractional retinal detachments: surgical experiences from a large tertiary academic institution.","authors":"Albert Liao, Blake Fortes, Adrian Au, Kirk Hou","doi":"10.1097/ICU.0000000000001124","DOIUrl":"10.1097/ICU.0000000000001124","url":null,"abstract":"<p><strong>Purpose of review: </strong>Management of diabetic tractional retinal detachments (TRDs) remains technically challenging. The purpose of this review is to provide an updated overview of current surgical techniques and important considerations when treating this condition.</p><p><strong>Recent findings: </strong>Recent advances in imaging have provided critical insights into hyaloid status and tractional forces in diabetic TRDs, greatly aiding surgical planning. Updates in vitrectomy instruments have also greatly improved anatomic success rates. However, a comprehensive preoperative evaluation and plan remains key in optimizing visual outcomes for this difficult condition.</p><p><strong>Summary: </strong>The surgical management of diabetic TRDs requires several key elements for successful outcomes. Timely intervention and presurgical planning are crucial, particularly in rapidly progressing cases. The use of advanced imaging and instruments enhances visualization and precision during surgery. Finally, a collaborative multispecialty approach with clear communication with patients about their prognosis is fundamental to effective care. These strategies collectively improve patient outcomes and promote visual recovery in those affected by diabetic TRDs.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"177-181"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment approaches for refractory full-thickness macular holes. 难治性全层黄斑孔的治疗方法。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-06 DOI: 10.1097/ICU.0000000000001131
Nikhil Bommakanti, Roselind Ni, Ajay E Kuriyan

Purpose of review: Full-thickness macular holes (FTMH) can result in significant visual impairment if untreated. Although conventional treatment achieves high closure rates, FTMH can persist or reopen in some cases. This review examines recent advances in surgical approaches for managing refractory FTMH and highlights their effectiveness and limitations.

Recent findings: Approaches to refractory FTMH aim to relieve traction, encourage glial cell proliferation, improve RPE pump efficiency, increase retinal compliance, and/or provide replacement tissue. A variety of techniques targeting these mechanisms, including various autologous or allogeneic transplants such as internal limiting membrane (ILM) or human amniotic membrane grafts, or surgical manipulations such as macular detachment or relaxing retinotomies, have been proposed. These techniques are reviewed here.

Summary: Multiple techniques have shown promise for refractory FTMH. Choice of technique should be guided by characteristics of the FTMH, including size and chronicity, availability of desired tissue or instrumentation, and surgeon familiarity.

综述目的:全层黄斑裂孔(FTMH)如果不及时治疗可导致严重的视力损害。虽然常规治疗可以达到很高的愈合率,但在某些情况下,FTMH可能会持续存在或重新打开。本文回顾了治疗难治性FTMH的手术方法的最新进展,并强调了其有效性和局限性。近期研究发现:治疗难治性FTMH的方法旨在缓解牵引力、促进胶质细胞增殖、提高RPE泵效率、增加视网膜顺应性和/或提供替代组织。针对这些机制的各种技术,包括各种自体或异体移植,如内限制膜(ILM)或人羊膜移植,或手术操作,如黄斑脱离或松弛性视网膜切除术,已经被提出。这里对这些技术进行了回顾。摘要:多种技术已经显示出难治性FTMH的前景。技术的选择应根据FTMH的特点来指导,包括大小和慢性、所需组织或内固定的可用性以及外科医生的熟悉程度。
{"title":"Treatment approaches for refractory full-thickness macular holes.","authors":"Nikhil Bommakanti, Roselind Ni, Ajay E Kuriyan","doi":"10.1097/ICU.0000000000001131","DOIUrl":"10.1097/ICU.0000000000001131","url":null,"abstract":"<p><strong>Purpose of review: </strong>Full-thickness macular holes (FTMH) can result in significant visual impairment if untreated. Although conventional treatment achieves high closure rates, FTMH can persist or reopen in some cases. This review examines recent advances in surgical approaches for managing refractory FTMH and highlights their effectiveness and limitations.</p><p><strong>Recent findings: </strong>Approaches to refractory FTMH aim to relieve traction, encourage glial cell proliferation, improve RPE pump efficiency, increase retinal compliance, and/or provide replacement tissue. A variety of techniques targeting these mechanisms, including various autologous or allogeneic transplants such as internal limiting membrane (ILM) or human amniotic membrane grafts, or surgical manipulations such as macular detachment or relaxing retinotomies, have been proposed. These techniques are reviewed here.</p><p><strong>Summary: </strong>Multiple techniques have shown promise for refractory FTMH. Choice of technique should be guided by characteristics of the FTMH, including size and chronicity, availability of desired tissue or instrumentation, and surgeon familiarity.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"219-226"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143574206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial. 社论。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-03-27 DOI: 10.1097/ICU.0000000000001122
Sunir J Garg, Jason Hsu
{"title":"Editorial.","authors":"Sunir J Garg, Jason Hsu","doi":"10.1097/ICU.0000000000001122","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001122","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 3","pages":"227-228"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143722495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Promising therapeutic targets for neuroprotection in retinal disease. 视网膜疾病神经保护的有前景的治疗靶点。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-10 DOI: 10.1097/ICU.0000000000001123
Warren W Pan, Thomas J Wubben, David N Zacks

Purpose of review: Neurodegeneration is a common endpoint of various blinding retinal diseases. Yet, despite exciting advances in disease treatment, there continues to exist a critical need for the development of neuroprotective strategies to prevent retinal cell death. Here, we summarize the recent advances in neuroprotective strategies.

Recent findings: From laboratory deciphering of the mechanisms involved in disease, many novel neuroprotective strategies have emerged and are currently under investigation for the treatment of various retinal and ocular diseases such as inherited retinal degeneration, retinal detachment, diabetic retinopathy, age-related macular degeneration, macular telangiectasia type 2, and glaucoma. These strategies include gene therapies, Fas inhibition, and targeting inflammatory, metabolic and reduction-oxidation abnormalities. Interestingly, investigation of several treatments across different diseases suggests shared neuroprotection mechanisms that can be targeted regardless of the particular disease.

Summary: Retinal neuroprotection can improve treatment of different retinal diseases. Fortunately, the current landscape, with a plethora of novel neuroprotective therapies, portends a better future for patients.

综述目的:神经变性是各种致盲性视网膜疾病的常见终点。然而,尽管疾病治疗取得了令人兴奋的进展,但仍然迫切需要开发神经保护策略来防止视网膜细胞死亡。在这里,我们总结了神经保护策略的最新进展。最近的发现:从实验室对疾病机制的解读中,许多新的神经保护策略已经出现,目前正在研究用于治疗各种视网膜和眼部疾病,如遗传性视网膜变性、视网膜脱离、糖尿病性视网膜病变、年龄相关性黄斑变性、2型黄斑毛细血管扩张和青光眼。这些策略包括基因治疗、Fas抑制以及针对炎症、代谢和还原氧化异常。有趣的是,对不同疾病的几种治疗方法的研究表明,无论特定疾病如何,都可以针对共同的神经保护机制。摘要:视网膜神经保护可以改善不同视网膜疾病的治疗。幸运的是,目前的情况是,大量新的神经保护疗法预示着患者的未来会更好。
{"title":"Promising therapeutic targets for neuroprotection in retinal disease.","authors":"Warren W Pan, Thomas J Wubben, David N Zacks","doi":"10.1097/ICU.0000000000001123","DOIUrl":"10.1097/ICU.0000000000001123","url":null,"abstract":"<p><strong>Purpose of review: </strong>Neurodegeneration is a common endpoint of various blinding retinal diseases. Yet, despite exciting advances in disease treatment, there continues to exist a critical need for the development of neuroprotective strategies to prevent retinal cell death. Here, we summarize the recent advances in neuroprotective strategies.</p><p><strong>Recent findings: </strong>From laboratory deciphering of the mechanisms involved in disease, many novel neuroprotective strategies have emerged and are currently under investigation for the treatment of various retinal and ocular diseases such as inherited retinal degeneration, retinal detachment, diabetic retinopathy, age-related macular degeneration, macular telangiectasia type 2, and glaucoma. These strategies include gene therapies, Fas inhibition, and targeting inflammatory, metabolic and reduction-oxidation abnormalities. Interestingly, investigation of several treatments across different diseases suggests shared neuroprotection mechanisms that can be targeted regardless of the particular disease.</p><p><strong>Summary: </strong>Retinal neuroprotection can improve treatment of different retinal diseases. Fortunately, the current landscape, with a plethora of novel neuroprotective therapies, portends a better future for patients.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"247-252"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143383597","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advancements in optic disc pit maculopathy management. 视盘斑窝病治疗的最新进展。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-05-01 Epub Date: 2025-02-12 DOI: 10.1097/ICU.0000000000001130
Tadashi Yokoi, Roselind L Ni, Meera D Sivalingam, Yoshihiro Yonekawa

Purpose of review: Optic disc pit maculopathy (ODPM) is a rare yet serious condition that can lead to visual impairment. While pars plana vitrectomy (PPV) remains the gold standard for ODPM that requires treatment, there is ongoing debate regarding adjunctive surgical techniques. This review explores the latest surgical advancements and innovations in the management of ODPM from the past few years.

Recent findings: Vitrectomy remains an effective procedure for ODPM management, achieving high success rates. Adjunctive techniques, including internal limiting membrane (ILM) peeling, gas tamponade, and juxtapapillary laser photocoagulation, have demonstrated efficacy, though their roles remain debated. Novel approaches using ILM plugging, amniotic membrane grafts, and autologous platelet concentrate offer promise, especially in refractory cases. High-level evidence remains scarce, and most recent publications are relatively small case series. Therefore, it remains unclear whether the additional techniques confer additional benefit beyond vitrectomy alone, although the novel approaches can be effective options for refractory cases. Larger comparative studies are required to provide better evidence.

Summary: Vitrectomy with or without additional maneuvers is an effective treatment for ODPM. Emerging adjunctive surgical techniques provide new possibilities, but further research is required to assess for comparative efficacy and optimize outcomes.

回顾目的:视盘斑点病是一种罕见但严重的疾病,可导致视力损害。虽然玻璃体切割(PPV)仍然是需要治疗的ODPM的金标准,但关于辅助手术技术的争论正在进行。这篇综述探讨了过去几年ODPM管理的最新外科进展和创新。最近的研究结果:玻璃体切除术仍然是治疗ODPM的有效方法,成功率很高。辅助技术,包括内限制膜(ILM)剥离、气体填塞和乳头旁激光光凝,已经证明了有效性,尽管它们的作用仍存在争议。新的方法,如ILM堵塞,羊膜移植和自体浓缩血小板提供了希望,特别是在难治性病例。高水平的证据仍然很少,最近的出版物是相对较小的病例系列。因此,除了单纯的玻璃体切除术外,其他技术是否能带来额外的益处尚不清楚,尽管这些新方法对难治性病例是有效的选择。需要更大规模的比较研究来提供更好的证据。总结:玻璃体切除术加或不加其他手术是治疗ODPM的有效方法。新兴的辅助手术技术提供了新的可能性,但需要进一步的研究来评估比较疗效和优化结果。
{"title":"Recent advancements in optic disc pit maculopathy management.","authors":"Tadashi Yokoi, Roselind L Ni, Meera D Sivalingam, Yoshihiro Yonekawa","doi":"10.1097/ICU.0000000000001130","DOIUrl":"10.1097/ICU.0000000000001130","url":null,"abstract":"<p><strong>Purpose of review: </strong>Optic disc pit maculopathy (ODPM) is a rare yet serious condition that can lead to visual impairment. While pars plana vitrectomy (PPV) remains the gold standard for ODPM that requires treatment, there is ongoing debate regarding adjunctive surgical techniques. This review explores the latest surgical advancements and innovations in the management of ODPM from the past few years.</p><p><strong>Recent findings: </strong>Vitrectomy remains an effective procedure for ODPM management, achieving high success rates. Adjunctive techniques, including internal limiting membrane (ILM) peeling, gas tamponade, and juxtapapillary laser photocoagulation, have demonstrated efficacy, though their roles remain debated. Novel approaches using ILM plugging, amniotic membrane grafts, and autologous platelet concentrate offer promise, especially in refractory cases. High-level evidence remains scarce, and most recent publications are relatively small case series. Therefore, it remains unclear whether the additional techniques confer additional benefit beyond vitrectomy alone, although the novel approaches can be effective options for refractory cases. Larger comparative studies are required to provide better evidence.</p><p><strong>Summary: </strong>Vitrectomy with or without additional maneuvers is an effective treatment for ODPM. Emerging adjunctive surgical techniques provide new possibilities, but further research is required to assess for comparative efficacy and optimize outcomes.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"210-218"},"PeriodicalIF":3.0,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143450535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial introduction. 编辑介绍。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-02 DOI: 10.1097/ICU.0000000000001114
{"title":"Editorial introduction.","authors":"","doi":"10.1097/ICU.0000000000001114","DOIUrl":"https://doi.org/10.1097/ICU.0000000000001114","url":null,"abstract":"","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":"36 2","pages":"v"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143257297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implications of myopia in diagnosis and screening of open angle glaucoma. 近视在开角型青光眼诊断和筛查中的意义。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-12-23 DOI: 10.1097/ICU.0000000000001116
Aiko Iwase, Makoto Araie

Purpose of review: Rapid increase in the prevalence of myopia has been documented worldwide. Myopia, especially high myopia, is not only an important risk factor for having open angle glaucoma (OAG), but also has a strong linking with the progression of OAG. Since myopic axial length (AXL) elongation is associated with nonglaucomatous optic nerve head (ONH) and visual field abnormalities, myopia poses a challenge in differential diagnosis of OAG. This review provides an overview of literature studying relationships between myopic AXL-elongation and diagnosis and prognosis of OAG, and functional and structural changes in the eye.

Recent findings: Studies using optical coherence tomography (OCT), OCT-angiography, those using standard automated perimetry (SAP), other perimetric or electrophysiological methods showed dose-dependent effects of myopic AXL elongation on the structural changes in the ONH and parapapillary tissues, and functional abnormalities of an eye. Large cohort studies showed approximately one quarter of eyes with nonpathologic high myopia were complicated with various patterns of visual field defects including glaucoma-like ones.

Summary: Findings of cross-sectional and longitudinal studies obtained using various fundus imaging devices must be integrated to perimetric results to improve differential diagnosis of OAG in myopic eyes, in which artificial intelligence technology may be useful.

综述目的:世界范围内的近视发病率迅速上升。近视尤其是高度近视不仅是开角型青光眼的重要危险因素,而且与开角型青光眼的发展密切相关。由于近视轴长(AXL)延长与非青光眼性视神经头(ONH)和视野异常有关,因此近视对OAG的鉴别诊断提出了挑战。本文就近视眼axl -伸长与OAG的诊断、预后以及眼内功能和结构变化关系的研究文献进行综述。最新发现:使用光学相干断层扫描(OCT)、OCT血管造影、标准自动视距测量(SAP)、其他视距测量或电生理方法的研究表明,近视AXL伸长对ONH和乳头旁组织的结构变化和眼睛功能异常具有剂量依赖性。大型队列研究显示,约四分之一的非病理性高度近视患者伴有各种类型的视野缺损,包括青光眼样的缺损。摘要:使用各种眼底成像设备所获得的横断面和纵向研究结果必须与周边测量结果相结合,以提高近视眼OAG的鉴别诊断,其中人工智能技术可能有用。
{"title":"Implications of myopia in diagnosis and screening of open angle glaucoma.","authors":"Aiko Iwase, Makoto Araie","doi":"10.1097/ICU.0000000000001116","DOIUrl":"10.1097/ICU.0000000000001116","url":null,"abstract":"<p><strong>Purpose of review: </strong>Rapid increase in the prevalence of myopia has been documented worldwide. Myopia, especially high myopia, is not only an important risk factor for having open angle glaucoma (OAG), but also has a strong linking with the progression of OAG. Since myopic axial length (AXL) elongation is associated with nonglaucomatous optic nerve head (ONH) and visual field abnormalities, myopia poses a challenge in differential diagnosis of OAG. This review provides an overview of literature studying relationships between myopic AXL-elongation and diagnosis and prognosis of OAG, and functional and structural changes in the eye.</p><p><strong>Recent findings: </strong>Studies using optical coherence tomography (OCT), OCT-angiography, those using standard automated perimetry (SAP), other perimetric or electrophysiological methods showed dose-dependent effects of myopic AXL elongation on the structural changes in the ONH and parapapillary tissues, and functional abnormalities of an eye. Large cohort studies showed approximately one quarter of eyes with nonpathologic high myopia were complicated with various patterns of visual field defects including glaucoma-like ones.</p><p><strong>Summary: </strong>Findings of cross-sectional and longitudinal studies obtained using various fundus imaging devices must be integrated to perimetric results to improve differential diagnosis of OAG in myopic eyes, in which artificial intelligence technology may be useful.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"107-114"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142869787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifestyle modifications and environmental risk factors for glaucoma. 青光眼的生活方式改变和环境风险因素。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-10-23 DOI: 10.1097/ICU.0000000000001098
Abdelrahman M Elhusseiny, Ahmad A Aref

Purpose of review: To summarize recent evidence about the association between different lifestyle modifications and environmental risk factors and glaucoma.

Recent findings: Incorporating moderate exercise into the routine of glaucoma patients may help slow the progression of the condition. However, caution should be taken when using swim goggles, and it may be advisable to avoid certain yoga positions and heavy weight-lifting exercises, as they have been linked to intraocular pressure (IOP) spikes and potential risks for glaucoma patients. Various relaxation techniques may lower IOP. The evidence remains inconclusive about the association between vitamins intake and glaucoma. Dietary nitric oxide has been associated with a lower risk of glaucoma. Higher smoking intensity has been linked to faster visual field decline and retinal nerve fiber layer thinning. Additionally, there is currently insufficient evidence to support the use of marijuana in managing glaucoma, with side effects outweighing the proposed benefits. A significant association has been found between air pollutants and ganglion cell layer thinning, as well as a greater burden of glaucoma.

Summary: Lifestyle and environmental factors are increasingly recognized as significant contributors to glaucoma development and progression. These modifications should be integrated into a comprehensive treatment approach alongside medications or surgical interventions.

综述的目的:总结有关不同生活方式的改变和环境风险因素与青光眼之间关系的最新证据:将适度运动纳入青光眼患者的日常生活习惯可能有助于减缓病情的发展。然而,在使用泳镜时应小心谨慎,最好避免某些瑜伽姿势和举重运动,因为它们与眼压飙升和青光眼患者的潜在风险有关。各种放松技巧可降低眼压。关于维生素摄入量与青光眼之间的关系,目前尚无定论。膳食中的一氧化氮与降低青光眼风险有关。较高的吸烟强度与较快的视野下降和视网膜神经纤维层变薄有关。此外,目前还没有足够的证据支持使用大麻来治疗青光眼,因为大麻的副作用超过了所建议的益处。总结:生活方式和环境因素越来越被认为是导致青光眼发生和发展的重要因素。这些改变应与药物或手术干预一起纳入综合治疗方法中。
{"title":"Lifestyle modifications and environmental risk factors for glaucoma.","authors":"Abdelrahman M Elhusseiny, Ahmad A Aref","doi":"10.1097/ICU.0000000000001098","DOIUrl":"10.1097/ICU.0000000000001098","url":null,"abstract":"<p><strong>Purpose of review: </strong>To summarize recent evidence about the association between different lifestyle modifications and environmental risk factors and glaucoma.</p><p><strong>Recent findings: </strong>Incorporating moderate exercise into the routine of glaucoma patients may help slow the progression of the condition. However, caution should be taken when using swim goggles, and it may be advisable to avoid certain yoga positions and heavy weight-lifting exercises, as they have been linked to intraocular pressure (IOP) spikes and potential risks for glaucoma patients. Various relaxation techniques may lower IOP. The evidence remains inconclusive about the association between vitamins intake and glaucoma. Dietary nitric oxide has been associated with a lower risk of glaucoma. Higher smoking intensity has been linked to faster visual field decline and retinal nerve fiber layer thinning. Additionally, there is currently insufficient evidence to support the use of marijuana in managing glaucoma, with side effects outweighing the proposed benefits. A significant association has been found between air pollutants and ganglion cell layer thinning, as well as a greater burden of glaucoma.</p><p><strong>Summary: </strong>Lifestyle and environmental factors are increasingly recognized as significant contributors to glaucoma development and progression. These modifications should be integrated into a comprehensive treatment approach alongside medications or surgical interventions.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"115-121"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New treatments for glaucoma. 青光眼的新疗法。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-09 DOI: 10.1097/ICU.0000000000001110
Anthony P Mai, Tanner J Ferguson, Nathan Radcliffe

Purpose of review: This review highlights new Federal Drug Administration (FDA) approved glaucoma treatments to familiarize providers with immediately available options.

Recent findings: New FDA-approved treatments include the bimatoprost implant, travoprost implant, direct selective laser trabeculoplasty (DSLT), and ocular pressure adjusting pump. The bimatoprost implant is approved for a single administration with effects lasting for about 1 year, as opposed to the nearly 3-year effect for the travoprost implant. Meanwhile, the DSLT lowers intraocular pressure (IOP) by applying a laser through the limbus within 2 s. Lastly, the ocular pressure adjusting pump is a noninvasive, nonpharmaceutical device that lowers IOP with negative pressure within a pair of goggles. Not only do these modalities lower IOP, but they also improve the patient experience by reducing drop burden, decreasing laser duration, or lowering side effects. Although the list of therapies still in development is extensive, another two promising devices under review include a supraciliary stent and an adjustable aqueous tube shunt.

Summary: Glaucoma treatment has considerably evolved over the last decade with the introduction of novel topical medications, minimally invasive glaucoma surgeries, sustained-release drug delivery systems, and wearable devices. This expansion in glaucoma has enabled more patient-centric decision-making regarding treatment.

综述目的:本综述强调了美国联邦药物管理局(FDA)批准的新的青光眼治疗方法,以使提供者熟悉立即可用的选择。最新发现:fda批准的新疗法包括比马前列素植入物、曲伏前列素植入物、直接选择性激光小梁成形术(DSLT)和眼压调节泵。比马前列素植入物被批准为单次给药,效果持续约1年,而曲伏前列素植入物的效果持续近3年。同时,DSLT通过在2秒内通过角膜缘照射激光来降低眼压。最后,眼压调节泵是一种无创、非药物装置,可在一副护目镜内以负压降低眼压。这些方法不仅可以降低IOP,而且还可以通过减少眼压、缩短激光持续时间或降低副作用来改善患者的体验。尽管仍在开发的治疗方法有很多,但另外两种有前景的设备正在审查中,包括辅助支架和可调节的水管分流器。摘要:青光眼的治疗在过去十年中有了很大的发展,引入了新的局部药物,微创青光眼手术,缓释药物输送系统和可穿戴设备。青光眼的扩大使得治疗决策更加以患者为中心。
{"title":"New treatments for glaucoma.","authors":"Anthony P Mai, Tanner J Ferguson, Nathan Radcliffe","doi":"10.1097/ICU.0000000000001110","DOIUrl":"10.1097/ICU.0000000000001110","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review highlights new Federal Drug Administration (FDA) approved glaucoma treatments to familiarize providers with immediately available options.</p><p><strong>Recent findings: </strong>New FDA-approved treatments include the bimatoprost implant, travoprost implant, direct selective laser trabeculoplasty (DSLT), and ocular pressure adjusting pump. The bimatoprost implant is approved for a single administration with effects lasting for about 1 year, as opposed to the nearly 3-year effect for the travoprost implant. Meanwhile, the DSLT lowers intraocular pressure (IOP) by applying a laser through the limbus within 2 s. Lastly, the ocular pressure adjusting pump is a noninvasive, nonpharmaceutical device that lowers IOP with negative pressure within a pair of goggles. Not only do these modalities lower IOP, but they also improve the patient experience by reducing drop burden, decreasing laser duration, or lowering side effects. Although the list of therapies still in development is extensive, another two promising devices under review include a supraciliary stent and an adjustable aqueous tube shunt.</p><p><strong>Summary: </strong>Glaucoma treatment has considerably evolved over the last decade with the introduction of novel topical medications, minimally invasive glaucoma surgeries, sustained-release drug delivery systems, and wearable devices. This expansion in glaucoma has enabled more patient-centric decision-making regarding treatment.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"135-139"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958354","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overlap syndrome: a case series and literature review of concurrent pigment dispersion and pseudoexfoliation syndromes. 重叠综合征:并发色素分散和假性剥脱综合征的病例系列和文献综述。
IF 3 2区 医学 Q1 OPHTHALMOLOGY Pub Date : 2025-03-01 Epub Date: 2024-11-07 DOI: 10.1097/ICU.0000000000001107
Pooja Shah, Srinath Soundararajan, David Fleischman

Purpose of review: The purpose of this review is to present two cases of overlap syndrome, or concurrent pigment dispersion syndrome and pseudoexfoliation syndrome. The summary of existing literature highlights the importance of accurate diagnosis and potential treatment options of overlap syndrome.

Recent findings: The cases describe two patients with overlap syndrome and resulting progressive glaucoma. The condition tends to present after age 50 years old, with presence of both pseudoexfoliative material and pigment dispersion signs. The pigment dispersion syndrome may be quiescent at the time of pseudoexfoliation onset and may have gone undiagnosed. This form of glaucoma poses challenges in controlling intraocular pressure and may progress rapidly, often requiring surgical intervention.

Summary: This paper reviews the common examination findings of pigment dispersion syndrome and pseudoexfoliation, which may aid clinicians in the diagnosis of the rare condition, overlap syndrome. The connection between the two conditions remains unclear, though studies of possible genetic associations are underway. The two-hit theory, or initial damage to the trabecular meshwork increasing susceptibility to future damage, is plausible given the severe nature of the condition. Though definitive conclusions regarding treatment strategies and outcomes of overlap syndrome are lacking, increased awareness, diagnosis, and study of the condition may help guide the management of overlap syndrome.

综述的目的:本综述旨在介绍两例重叠综合征或并发色素分散综合征和假性剥脱综合征的病例。对现有文献的总结强调了准确诊断的重要性以及重叠综合征的潜在治疗方案:这些病例描述了两名患有重叠综合征并导致进展性青光眼的患者。该病多在 50 岁以后发病,同时伴有假性角膜剥脱物和色素分散征。色素分散综合征在假性角膜外翻发病时可能处于静止状态,也可能未被诊断出来。总结:本文回顾了色素分散综合征和假性角膜外翻的常见检查结果,这可能有助于临床医生诊断重叠综合征这一罕见疾病。这两种疾病之间的联系仍不清楚,但可能的遗传关联研究正在进行中。鉴于该病的严重性,"两击理论"(即小梁网最初的损伤增加了未来损伤的易感性)是可信的。虽然目前还没有关于重叠综合征治疗策略和结果的明确结论,但提高对这种疾病的认识、诊断和研究可能有助于指导重叠综合征的治疗。
{"title":"Overlap syndrome: a case series and literature review of concurrent pigment dispersion and pseudoexfoliation syndromes.","authors":"Pooja Shah, Srinath Soundararajan, David Fleischman","doi":"10.1097/ICU.0000000000001107","DOIUrl":"10.1097/ICU.0000000000001107","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review is to present two cases of overlap syndrome, or concurrent pigment dispersion syndrome and pseudoexfoliation syndrome. The summary of existing literature highlights the importance of accurate diagnosis and potential treatment options of overlap syndrome.</p><p><strong>Recent findings: </strong>The cases describe two patients with overlap syndrome and resulting progressive glaucoma. The condition tends to present after age 50 years old, with presence of both pseudoexfoliative material and pigment dispersion signs. The pigment dispersion syndrome may be quiescent at the time of pseudoexfoliation onset and may have gone undiagnosed. This form of glaucoma poses challenges in controlling intraocular pressure and may progress rapidly, often requiring surgical intervention.</p><p><strong>Summary: </strong>This paper reviews the common examination findings of pigment dispersion syndrome and pseudoexfoliation, which may aid clinicians in the diagnosis of the rare condition, overlap syndrome. The connection between the two conditions remains unclear, though studies of possible genetic associations are underway. The two-hit theory, or initial damage to the trabecular meshwork increasing susceptibility to future damage, is plausible given the severe nature of the condition. Though definitive conclusions regarding treatment strategies and outcomes of overlap syndrome are lacking, increased awareness, diagnosis, and study of the condition may help guide the management of overlap syndrome.</p>","PeriodicalId":50604,"journal":{"name":"Current Opinion in Ophthalmology","volume":" ","pages":"122-129"},"PeriodicalIF":3.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142607464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Opinion in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1